{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:21:01Z","timestamp":1791030061565,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Although low absolute values of bone mineral density (BMD) predict increased fracture risk in osteoporosis, it is not certain how well increases in BMD with antiresorptive therapy predict observed reductions in fracture risk. This work examines the relationships between changes in BMD after 1 year or 3 years of raloxifene or placebo therapy and the risk for new vertebral fractures at 3 years. In the Multiple Outcomes of Raloxifene Evaluation (MORE) trial, 7705 postmenopausal women with osteoporosis were randomized to placebo or raloxifene 60 mg\/day or 120 mg\/day. Relationships between baseline BMD and changes in BMD from baseline with the risk of new vertebral fractures were analyzed in this cohort using logistic regression models with the raloxifene doses pooled. As has been observed in other populations, women with the lowest baseline lumbar spine or femoral neck BMD in the MORE cohort had the greatest risk for vertebral fractures. Furthermore, for any percentage change, either increase or decrease in femoral neck or lumbar spine BMD at 1 year or 3 years, raloxifene-treated patients had a statistically significantly lower vertebral fracture risk compared with placebo-treated patients. The decrease in fracture risk with raloxifene was similar across the range of percentage change in femoral neck BMD observed at 3 years; patients receiving raloxifene had a 36% lower risk of vertebral fracture compared with those receiving placebo. At any percentage change in femoral neck and lumbar spine BMD observed at 1 year, raloxifene treatment decreased the risks of new vertebral fractures at 3 years by 38% and 41%, respectively. The logistic regression model showed that the percentage changes in BMD with raloxifene treatment accounted for 4% of the observed vertebral fracture risk reduction, and the other 96% of the risk reduction remains unexplained. The present data show that the measured BMD changes observed with raloxifene therapy are poor predictors of vertebral fracture risk reduction with raloxifene therapy.<\/jats:p>","DOI":"10.1359\/jbmr.2002.17.1.1","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T04:06:42Z","timestamp":1146110802000},"page":"1-10","source":"Crossref","is-referenced-by-count":362,"title":["Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy"],"prefix":"10.1093","volume":"17","author":[{"given":"Somnath","family":"Sarkar","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce H.","family":"Mitlak","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayme","family":"Wong","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Stock","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M.","family":"Black","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine D.","family":"Harper","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,10,24]]},"reference":[{"key":"2024013019035262900_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s001980050224","article-title":"Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis","volume":"10","author":"Genant","year":"2000","journal-title":"Osteoporos Int"},{"key":"2024013019035262900_bib2","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/jbmr.5650081010","article-title":"Long-term fracture prediction by bone mineral assessed at different skeletal sites","volume":"8","author":"Melton","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024013019035262900_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S8756-3282(98)00150-1","article-title":"Secondary osteoporosis and the risk of vertebral deformities in women","volume":"24","author":"Melton","year":"1999","journal-title":"Bone"},{"key":"2024013019035262900_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-114-11-919","article-title":"Pre-existing fractures and bone mass predict vertebral fracture incidence in women","volume":"114","author":"Ross","year":"1991","journal-title":"Ann Intern Med"},{"key":"2024013019035262900_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture","volume":"285","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"key":"2024013019035262900_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","article-title":"Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group","volume":"14","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024013019035262900_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"2024013019035262900_bib8","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"2024013019035262900_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0889-857X(05)70192-7","article-title":"The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis","volume":"27","author":"Lufkin","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"2024013019035262900_bib10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJM199803123381107","article-title":"Treatment of postmenopausal osteoporosis","volume":"338","author":"Eastell","year":"1998","journal-title":"N Engl J Med"},{"key":"2024013019035262900_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/0003-4819-125-7-199610010-00011","article-title":"Surrogate end points in clinical trials: Are we being misled?","volume":"125","author":"Fleming","year":"1996","journal-title":"Ann Intern Med"},{"key":"2024013019035262900_bib12","first-page":"S158","article-title":"What proportion of the effects of raloxifene (RLX) on vertebral fracture risk can be directly attributed to its bone mineral density (BMD) effects?","volume":"14","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024013019035262900_bib13","first-page":"S159","article-title":"How much of the reduction in risk of vertebral fractures by alendronate is explained by increased spine BMD?","volume":"14","author":"Cummings","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024013019035262900_bib14","first-page":"S137","article-title":"Predicting the effect of antiresorptive treatments on risk of vertebral fractures: A meta-analysis","volume":"14","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024013019035262900_bib15","first-page":"S102","article-title":"Changes in BMD substantially underestimate the anti-fracture effects of alendronate and other antiresorptive drugs","volume":"11","author":"Cummings","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024013019035262900_bib16","first-page":"S203","article-title":"BMD changes explains only a fraction of the observed fracture risk reduction in risedronate-treated patients","volume":"11","author":"Watts","year":"2000","journal-title":"Osteoporos Int"},{"key":"2024013019035262900_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Monographs on Statistics and Applied Probability: Generalized Linear Models","author":"McCullagh","year":"1989","edition":"2nd ed."},{"key":"2024013019035262900_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/sim.4780110204","article-title":"Statistical validation of intermediate endpoints for chronic diseases","volume":"11","author":"Freedman","year":"1992","journal-title":"Stat Med"},{"key":"2024013019035262900_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","article-title":"Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group","volume":"341","author":"Cummings","year":"1993","journal-title":"Lancet"},{"key":"2024013019035262900_bib20","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"2024013019035262900_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jbmr.5650110510","article-title":"Dual X-ray absorptiometry quality control: Comparison of visual examination and process-control charts","volume":"11","author":"Lu","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024013019035262900_bib22","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/(SICI)1097-0258(19970830)16:16<1889::AID-SIM607>3.0.CO;2-V","article-title":"Comparative calibration without a gold standard","volume":"16","author":"Lu","year":"1997","journal-title":"Stat Med"},{"key":"2024013019035262900_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-6009(08)80203-6","article-title":"The association between age and bone mineral density in men and women aged 55 years and over: The Rotterdam Study","volume":"25","author":"Burger","year":"1994","journal-title":"Bone Miner"},{"key":"2024013019035262900_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s001980050008","article-title":"Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women","volume":"11","author":"Patel","year":"2000","journal-title":"Osteoporos Int"},{"key":"2024013019035262900_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1259\/0007-1285-65-771-213","article-title":"Bone mineral density in healthy normal women and reproducibility of measurements in spine and hip using dual-energy X-ray absorptiometry","volume":"65","author":"Haddaway","year":"1992","journal-title":"Br J Radiol"},{"issue":"Suppl 5","key":"2024013019035262900_bib26","first-page":"S93","article-title":"Validation of change in bone mineral density as a surrogate for fracture risk after statistical adjustment for imprecision in BMD measurements","volume":"28","author":"Watts","year":"2001","journal-title":"Bone"},{"key":"2024013019035262900_bib27","first-page":"1118","article-title":"Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density","volume":"80","author":"Glauber","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019035262900_bib28","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jbmr.5650110618","article-title":"Relationship between body composition and bone mass in women","volume":"11","author":"Khosla","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024013019035262900_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1359\/jbmr.2000.15.1.13","article-title":"Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis","volume":"15","author":"Legrand","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013019035262900_bib30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/BF02554913","article-title":"The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures","volume":"37","author":"Kleerekoper","year":"1985","journal-title":"Calcif Tissue Int"},{"key":"2024013019035262900_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/THC-1998-65-602","article-title":"The effect of modelling and remodelling on human vertebral body architecture","volume":"6","author":"Mosekilde","year":"1998","journal-title":"Technol Health Care"},{"key":"2024013019035262900_bib32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/BF02652563","article-title":"Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women","volume":"7","author":"Liu","year":"1997","journal-title":"Osteoporos Int"},{"key":"2024013019035262900_bib33","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1359\/jbmr.1997.12.7.1083","article-title":"Relationship of bone turnover to bone density and fractures","volume":"12","author":"Melton","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024013019035262900_bib34","doi-asserted-by":"crossref","first-page":"197S","DOI":"10.1016\/8756-3282(95)00502-1","article-title":"Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy","volume":"18","author":"Riggs","year":"1996","journal-title":"Bone"},{"key":"2024013019035262900_bib35","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U","article-title":"Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group","volume":"42","author":"Hochberg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2024013019035262900_bib36","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.283.10.1318","article-title":"Monitoring osteoporosis therapy with bone densitometry: Misleading changes and regression to the mean. Fracture Intervention Trial Research Group","volume":"283","author":"Cummings","year":"2000","journal-title":"JAMA"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2002.17.1.1","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/17\/1\/1\/56471385\/5650170101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/17\/1\/1\/56471385\/5650170101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:03:36Z","timestamp":1710342216000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/17\/1\/1-10\/7582600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,10,24]]},"published-print":{"date-parts":[[2002,1,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2002.17.1.1","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2002,1,1]]},"published":{"date-parts":[[2002,1,1]]}}}